Tag: regeneron

October 15, 2018

Aimmune Therapeutics Announces Initiation of Phase 2 Study With Regeneron and Sanofi of AR101

Aimmune Therapeutics (Nasdaq:AIMT) a biopharmaceutical company developing treatments for potentially life-threatening food allergies, today announced the initiation of a phase 2...
October 5, 2017

4 Gene Therapy Stocks to Watch in 2017

At the halfway mark of 2017, here's a look at how these four gene therapy companies are performing so far...
April 3, 2017

Sarepta Announces New Chief Medical Officer.

Sarepta Therapeutics (NASDAQ:SRPT) appointed Dr. Catherine Stehman-Breen as their new chief medical officer.
March 14, 2017

Trump's FDA Nominee Aligns With Changes To The Agency

Dr. Scott Gottlieb would be heading the FDA after a confirmation vote by the American Senate.
February 3, 2017

An Analyst’s Take on Drug Pricing and Catalysts in the Biotech Industry

In the first of a two-part series, analyst Hartaj Singh talks about the biotech industry in 2016 and 2017, drug...
December 27, 2016

Top Biotech News Stories of 2016

The following news stories made headlines in 2016, since they triggered major stock sell-offs in the sector. But it’s not...
December 16, 2016

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences and ERS Genomics Announce Global Agreement on the Foundational Intellectual Property for CRISPR/Cas9 Gene Editing Technology

CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and ERS Genomics announced that the companies and their licensors have entered into a...